1,4-Dioxane – What Now?

Event Info

Now that EPA has completed the risk evaluation of 1,4-Dioxane and found that several consumer uses do not present an unreasonable risk, what happens next?  Hear from the experts on the findings of the 1,4-dioxane risk evaluation, preemption under the Lautenberg Chemical Safety Act, and the potential implications to state and EPA activity involving 1,4-dioxane.

Speakers:

• Steve Bennett, SVP, Scientific & Regulatory Affairs, HCPA
• Jim Jones, Consultant, James J. Jones Environmental
• Michael Boucher, Partner, Crowell & Moring

If you have any questions regarding this event, please contact Cassy LaRussa clarussa@thehcpa.org

Who Should Attend?
Communications/Marketing
Executives
Legislative/Public Affairs
Managers
Quality Assurance
Regulatory Affairs
Research & Development
Risk Management

If you do not have an account with us, please use the link to create one prior to registering.